Persons with dispensed medicines; origin
Sex | Age | Origin | Medicine group (ATC) | Periods | Persons with medicines, relative (%) | Defined daily doses (DDD), relative (number per 1 000 persons) |
---|---|---|---|---|---|---|
T001038 | Total age | Total | Total | 2022* | 63.99 | 510,975 |
T001038 | Total age | Total | A Alimentary tract and metabolism | 2022* | 24.87 | 120,801 |
T001038 | Total age | Total | A01 Stomatological preparations | 2022* | 0.62 | 51 |
T001038 | Total age | Total | A01A Stomatological preparations | 2022* | 0.62 | 51 |
T001038 | Total age | Total | A02 Drugs for acid related disorders | 2022* | 12.48 | 45,198 |
T001038 | Total age | Total | A02A Antacids | 2022* | 0.00 | 1 |
T001038 | Total age | Total | A02B Drugs for peptic ulcer and gord | 2022* | 12.48 | 45,196 |
T001038 | Total age | Total | A02X Oth. drugs for acid related disord. | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A03 Drugs for funct.gastrointest.disord. | 2022* | 2.08 | 1,241 |
T001038 | Total age | Total | A03A Drugs for functional bowel disord. | 2022* | 0.50 | 945 |
T001038 | Total age | Total | A03B Belladonna and derivatives, plain | 2022* | 0.02 | 2 |
T001038 | Total age | Total | A03C Antispasmodics with psycholeptics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A03D Antispasmodics with analgesics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A03E Antispasmodics and anticholinergics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A03F Propulsives | 2022* | 1.61 | 295 |
T001038 | Total age | Total | A04 Antiemetics and antinauseants | 2022* | 0.74 | 69 |
T001038 | Total age | Total | A04A Antiemetics and antinauseants | 2022* | 0.74 | 69 |
T001038 | Total age | Total | A05 Bile and liver therapy | 2022* | 0.10 | 280 |
T001038 | Total age | Total | A05A Bile therapy | 2022* | 0.10 | 280 |
T001038 | Total age | Total | A05B Liver therapy, lipotropics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A06 Laxatives | 2022* | 8.59 | 8,027 |
T001038 | Total age | Total | A06A Laxatives | 2022* | 8.59 | 8,027 |
T001038 | Total age | Total | A07 Anti diarr/intest/infl/infect.agents | 2022* | 0.96 | 3,936 |
T001038 | Total age | Total | A07A Intestinal antiinfectives | 2022* | 0.36 | 69 |
T001038 | Total age | Total | A07B Intestinal adsorbents | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A07C Electrolytes with carbohydrates | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A07D Antipropulsives | 2022* | 0.12 | 113 |
T001038 | Total age | Total | A07E Intestinal antiinflammatory agents | 2022* | 0.49 | 3,754 |
T001038 | Total age | Total | A07F Antidiarrheal microorganisms | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A07X Other antidiarrheals | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A08 Antiobesity prep. excl.diet products | 2022* | 0.00 | 2 |
T001038 | Total age | Total | A08A Antiobesity prep.excl.diet products | 2022* | 0.00 | 2 |
T001038 | Total age | Total | A09 Digestives, incl. enzymes | 2022* | 0.12 | 331 |
T001038 | Total age | Total | A09A Digestives, incl. enzymes | 2022* | 0.12 | 331 |
T001038 | Total age | Total | A10 Drugs used in diabetes | 2022* | 4.85 | 29,172 |
T001038 | Total age | Total | A10A Insulins and analogues | 2022* | 1.54 | 7,936 |
T001038 | Total age | Total | A10B Blood glucose lowering drugs, excl. | 2022* | 4.28 | 21,236 |
T001038 | Total age | Total | A10X Other drugs used in diabetes | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A11 Vitamins | 2022* | 5.56 | 22,797 |
T001038 | Total age | Total | A11A Multivitamins, combinations | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A11B Multivitamins, plain | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A11C Vit A and D, incl.combin.of the two | 2022* | 5.55 | 22,789 |
T001038 | Total age | Total | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.01 | 4 |
T001038 | Total age | Total | A11E Vitamin B-complex, incl. combinat. | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A11G Ascorbic acid (vitamin C) + combin. | 2022* | 0.00 | 4 |
T001038 | Total age | Total | A11H Other plain vitamin preparations | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A11J Other vitamin products + combinat. | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A12 Mineral supplements | 2022* | 3.34 | 9,654 |
T001038 | Total age | Total | A12A Calcium | 2022* | 3.18 | 9,490 |
T001038 | Total age | Total | A12B Potassium | 2022* | 0.16 | 130 |
T001038 | Total age | Total | A12C Other mineral supplements | 2022* | 0.05 | 34 |
T001038 | Total age | Total | A13 Tonics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A13A Tonics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A14 Anabolic agents for systemic use | 2022* | 0.00 | 3 |
T001038 | Total age | Total | A14A Anabolic steroids | 2022* | 0.00 | 3 |
T001038 | Total age | Total | A14B Other anabolic agents | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A15 Appetite stimulants | 2022* | 0.00 | 0 |
T001038 | Total age | Total | A16 Other aliment.tract/metabol.products | 2022* | 0.02 | 41 |
T001038 | Total age | Total | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.02 | 41 |
T001038 | Total age | Total | B Blood and blood forming organs | 2022* | 13.22 | 50,481 |
T001038 | Total age | Total | B01 Antithrombotic agents | 2022* | 10.64 | 32,515 |
T001038 | Total age | Total | B01A Antithrombotic agents | 2022* | 10.64 | 32,515 |
T001038 | Total age | Total | B02 Antihemorrhagics | 2022* | 0.30 | 71 |
T001038 | Total age | Total | B02A Antifibrinolytics | 2022* | 0.22 | 43 |
T001038 | Total age | Total | B02B Vitamin k and other hemostatics | 2022* | 0.08 | 28 |
T001038 | Total age | Total | B03 Antianemic preparations | 2022* | 3.35 | 17,890 |
T001038 | Total age | Total | B03A Iron preparations | 2022* | 1.82 | 641 |
T001038 | Total age | Total | B03B Vitamin B12 and folic acid | 2022* | 1.69 | 17,249 |
T001038 | Total age | Total | B03X Other antianemic preparations | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B05 Blood substitutes / perfus.solutions | 2022* | 0.26 | 4 |
T001038 | Total age | Total | B05A Blood and related products | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B05B Intravenous solutions | 2022* | 0.25 | 4 |
T001038 | Total age | Total | B05C Irrigating solutions | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B05D Peritoneal dialytics | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B05X Intravenous solution additives | 2022* | 0.01 | 0 |
T001038 | Total age | Total | B05Z Hemodialytics and hemofiltrates | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B06 Other hematological agents | 2022* | 0.00 | 0 |
T001038 | Total age | Total | B06A Other hematological agents | 2022* | 0.00 | 0 |
T001038 | Total age | Total | C Cardiovascular system | 2022* | 21.25 | 163,444 |
T001038 | Total age | Total | C01 Cardiac therapy | 2022* | 2.53 | 5,148 |
T001038 | Total age | Total | C01A Cardiac glycosides | 2022* | 0.45 | 657 |
T001038 | Total age | Total | C01B Antiarrhythmics, class I and III | 2022* | 0.39 | 890 |
T001038 | Total age | Total | C01C Cardiac stimulants excl. glycosides | 2022* | 0.36 | 6 |
T001038 | Total age | Total | C01D Vasodilators used in card. diseases | 2022* | 1.40 | 3,406 |
T001038 | Total age | Total | C01E Other cardiac preparations | 2022* | 0.07 | 189 |
T001038 | Total age | Total | C02 Antihypertensives | 2022* | 0.32 | 1,153 |
T001038 | Total age | Total | C02A Antiadren.agents, centrally acting | 2022* | 0.07 | 139 |
T001038 | Total age | Total | C02B Antiadren.agents, ganglion-blocking | 2022* | 0.00 | 0 |
T001038 | Total age | Total | C02C Antiadren.agents, peripher. acting | 2022* | 0.24 | 980 |
T001038 | Total age | Total | C02D Arteriolar smooth muscle agents | 2022* | 0.00 | 3 |
T001038 | Total age | Total | C02K Other antihypertensives | 2022* | 0.01 | 31 |
T001038 | Total age | Total | C02L Antihypertensives/diuretics combin. | 2022* | 0.00 | 0 |
T001038 | Total age | Total | C02N Combinations of antihypertensives.. | 2022* | 0.00 | 0 |
T001038 | Total age | Total | C03 Diuretics | 2022* | 5.80 | 15,381 |
T001038 | Total age | Total | C03A Low-ceiling diuretics, thiazides | 2022* | 3.17 | 6,335 |
T001038 | Total age | Total | C03B Low-ceiling diuret.,excl. thiazides | 2022* | 0.35 | 752 |
T001038 | Total age | Total | C03C High-ceiling diuretics | 2022* | 1.96 | 6,801 |
T001038 | Total age | Total | C03D Potassium-sparing agents | 2022* | 1.15 | 1,284 |
T001038 | Total age | Total | C03E Diuretics/potassium-sparing agents | 2022* | 0.07 | 208 |
Source: CBS. |
Table explanation
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, origin, age and sex.
Data available from 2020.
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
- Defined daily doses (DDD), relative
- Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.
WHO: World Health Organisation, Wereldgezondheidsorganisatie